Additionally, insulin users with T2D were assessed for hypoglycaemia risk on a regular basis, with at least 80% of survey participants reporting frequent assessments for recurrent hypoglycaemia (80.0%) or severe hypoglycaemia (88.6) (Table S4). The gene discussed is INS; the disease is Hypoglycemia.